Bo Baldetorp
101 – 110 of 145
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1995
-
Mark
Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates
(
- Contribution to journal › Article
- 1994
-
Mark
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group
(
- Contribution to journal › Article
-
Mark
Abnormal DNA synthesis in polyamine deficient cells revealed by bromodeoxyuridine-flow cytometry technique
(
- Contribution to journal › Article
-
Mark
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
(
- Contribution to journal › Article
-
Mark
Inter-institutional reproducibility of flow cytometric DNA-analysis in breast carcinomas
(
- Contribution to journal › Article
-
Mark
An improved mathematical method to estimate DNA synthesis time of bromodeoxyuridine-labelled cells, using FCM-derived data
(
- Contribution to journal › Article
-
Mark
Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?
(
- Contribution to journal › Article
- 1993
-
Mark
DNA analysis as a predictor of the outcome of induction chemotherapy in advanced head and neck carcinomas
(
- Contribution to journal › Article
-
Mark
Comparative cytogenetic and DNA flow cytometric analysis of 150 bone and soft-tissue tumors
(
- Contribution to journal › Article
-
Mark
Liposarcoma: a population-based epidemiologic and prognostic study of features of 43 patients, including tumor DNA content
(
- Contribution to journal › Article